MedTrace Logo

A Registry Study on Tanreqing（a Chinese Medicine Injection）Used in Hospitals in China

NCT01824732 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 3000

Last updated 2013-04-05

No results posted yet for this study

Summary

This study was advocated by Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences in December 2012.

The purpose of this study is to make a event monitoring to see whether Tanreqing injection is safe and the characteristic and mechanism of anaphylactic reaction used Tanreqing injection in hospitals in China.

Conditions

  • Pneumonia;
  • Bronchitis

Sponsors & Collaborators

  • China Academy of Chinese Medical Sciences

    lead OTHER

Principal Investigators

  • Xie Y Ming, BA · China Academy of Chinese Medical Sciences

Eligibility

Min Age
1 Month
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2013-04-30
Completion
2013-04-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01824732 on ClinicalTrials.gov